Aptus Pharma Ltd.BSE: APPL

Aptus Pharma Ltd. Press Release Apr 28 2026

· Moneycontrol

Statement of Deviation(s) or Variation(s) in utilization of proceeds of initial Public Offer pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

View Attachment